However, no radiosensitization was achieved by bosutinib (Figure 4B), although bosutinib, similarly to dasatinib, efficiently reduced the increased plating efficiency of CAV1-expressing LNCaP PCa (Supplementary Figure S4). The gene discussed is CAV1; the disease is posterior cortical atrophy.